Search results
Results from the WOW.Com Content Network
The most dramatic symptoms of GCA (for example, visual loss) result directly from the inflammation of the large- and medium-sized cranial vessels. ... Giant cell arteritis is a systemic vasculitis ...
Introduction. Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related conditions that almost exclusively occur in the population aged over 50 years, with an average age of onset of ...
Every 10 μg/m 3 increase in PM 10 exposure in the preceding 60 days increased the incremental risk (IR) for giant cell arteritis by 27.1% (95% CI, 5.8-52.6). This association was more pronounced ...
The researchers defined sustained remission as the absence of giant cell arteritis symptoms, normalization of inflammatory laboratory tests, and tapering the use of prednisone. The cumulative ...
The sensitivity of temporal artery biopsy has been reported to be around 87%. [] Steps that may optimize the diagnostic accuracy of the biopsy are to arrange it as quickly as possible (within 2 ...
Long-Term Plan. The long-term therapy and surveillance of patients with GCA is important. The side effects of long-term steroid therapy are protean and must be addressed. All patients need ...
Giant cell arteritis is a common form of vasculitis among older adults. Although the diagnosis can be challenging, early recognition and prompt initiation of therapy can lead to rapid relief of ...
Once the symptoms have cleared and the tests have normalized, one tapers the prednisone from the 60 mg/day level by 5-10 mg every week. Invariably, the ESR will slowly increase once the steroids ...
In north-west Spain, IL-6 polymorphism was associated with expression of PMR symptoms in biopsy-proven GCA patients. ... Giant cell arteritis (GCA) is a medical emergency. The concept of symptom ...
Treatment of Relapsing GCA. Disease relapse in GCA can be defined as a rise in ESR above 40 mm/h, plus a return of symptoms of GCA, ischemic complications, unexplained fever or symptoms of PMR ...